Inactive Instrument

News BROE CAPI

Stocks

BCAC

US11374E1047

All News

22-08-18	BROE CAPI27 : INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS - Form 8-K/A	PU
22-08-18	Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-08-04	BROE CAPI27 : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	PU
22-08-01	Brookline Capital Acquisition : Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company - Form 8-K	PU
22-07-29	Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) dropped from NASDAQ Composite Index	CI
22-07-28	BROOKLINE CAPITAL ACQUISITION : AND APEXIGEN, INC. ANNOUNCE STOCKHOLDER APPROVAL OF BUSINESS COMBINATION - Form 8-K	PU
22-07-18	Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement and Annual Stockholder Meeting to Approve the Proposed Business Combination - Form 8-K	PU
22-06-30	Brookline Capital Acquisition : Confirms Receipt of Sponsor Funds to Extend Period of Time to Consummate Business Combination and for Additional Working Capital - Form 8-K	PU
22-05-23	Brookline Capital Acquisition : Quarterly Report (Form 10-Q)	PU
22-05-23	Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-05-01	Brookline Capital Acquisition Corp. announced that it has received $0.167032 million in funding from Brookline Capital Holdings, LLC	CI
22-04-26	Brookline Capital Acquisition : Announces Stockholder Approval of Extension Amendment to Complete its Business Combination with Apexigen, Inc - Form 8-K	PU
22-04-07	Brookline Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-04-06	Brookline Capital Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
22-03-18	Brookline Capital Acquisition : VIAVID communications simplified. Apexigen and Brookline Capital Acquisition Corp. Joint Conference Call - Form 8-K	PU
22-03-18	Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company - Form 8-K	PU
22-03-18	Blank Check Firm Brookline Capital Acquisition, Apexigen Enter Merger Agreement	MT
21-12-15	Brookline Capital Acquisition : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - Form 8-K	PU
21-11-24	Brookline Capital Acquisition : Amendment to Current Report (Form 8-K/A)	PU
21-08-16	Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
21-07-26	Certain Common Stock of Brookline Capital Acquisition Corp. are subject to a Lock-Up Agreement Ending on 27-JUL-2021.	CI
21-06-07	Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
21-06-07	Brookline Capital Acquisition : Quarterly Report (SEC Filing - 10-Q)	PU
21-06-04	Brookline Capital Acquisition : Receives Noncompliance Notice Regarding Late Form 10-Q Filing From Nasdaq (Form 8-K)	PU
21-02-23	Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) added to NASDAQ Composite Index	CI

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

News BROE CAPI

Stocks

BCAC

US11374E1047

All News

Filters